BOSTON SCIENTIFIC CORP financial data

Symbol
BSX on NYSE
Location
Marlborough, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 03 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 134% % -12%
Quick Ratio 52% % 6.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,482,442,039 shares 0.58%
Entity Public Float $113,100,000,000 USD 43%
Common Stock, Value, Issued $17,000,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 1,481,700,000 shares 0.61%
Weighted Average Number of Shares Outstanding, Diluted 1,495,500,000 shares 0.54%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $19,351,000,000 USD 22%
Operating Income (Loss) $3,463,000,000 USD 38%
Nonoperating Income (Expense) $311,000,000 USD -9.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,270,000,000 USD 49%
Income Tax Expense (Benefit) $485,000,000 USD 17%
Earnings Per Share, Basic 1 USD/shares 54%
Earnings Per Share, Diluted 1 USD/shares 55%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,275,000,000 USD -49%
Inventory, Net $2,921,000,000 USD 6.1%
Other Assets, Current $701,000,000 USD 4%
Assets, Current $8,035,000,000 USD -8.3%
Deferred Income Tax Assets, Net $3,669,000,000 USD -3.9%
Property, Plant and Equipment, Net $3,795,000,000 USD 24%
Operating Lease, Right-of-Use Asset $495,000,000 USD 16%
Intangible Assets, Net (Excluding Goodwill) $7,162,000,000 USD 24%
Goodwill $18,214,000,000 USD 21%
Other Assets, Noncurrent $1,832,000,000 USD 12%
Assets $42,707,000,000 USD 12%
Accounts Payable, Current $1,002,000,000 USD 10%
Employee-related Liabilities, Current $1,305,000,000 USD 17%
Accrued Liabilities, Current $2,981,000,000 USD 21%
Liabilities, Current $5,328,000,000 USD -9.8%
Long-term Debt and Lease Obligation $11,117,000,000 USD 20%
Accrued Income Taxes, Noncurrent $403,000,000 USD 11%
Deferred Income Tax Liabilities, Net $242,000,000 USD 75%
Operating Lease, Liability, Noncurrent $445,000,000 USD 19%
Other Liabilities, Noncurrent $2,390,000,000 USD 30%
Accumulated Other Comprehensive Income (Loss), Net of Tax $689,000,000 USD -438%
Retained Earnings (Accumulated Deficit) $4,899,000,000 USD 133%
Stockholders' Equity Attributable to Parent $23,394,000,000 USD 13%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $23,630,000,000 USD 13%
Liabilities and Equity $42,707,000,000 USD 12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $541,000,000 USD 230%
Net Cash Provided by (Used in) Financing Activities $233,000,000 USD -85%
Net Cash Provided by (Used in) Investing Activities $500,000,000 USD -75%
Common Stock, Shares Authorized 2,000,000,000 shares 0%
Common Stock, Shares, Issued 1,745,573,129 shares
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $314,000,000 USD -78%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,476,000,000 USD -44%
Deferred Tax Assets, Valuation Allowance $1,268,000,000 USD 3.9%
Deferred Tax Assets, Gross $4,990,000,000 USD -0.78%
Operating Lease, Liability $482,000,000 USD 3.4%
Depreciation $456,000,000 USD 16%
Payments to Acquire Property, Plant, and Equipment $187,000,000 USD 4.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $2,231,000,000 USD 54%
Lessee, Operating Lease, Liability, to be Paid $564,000,000 USD 4.6%
Property, Plant and Equipment, Gross $7,656,000,000 USD 14%
Operating Lease, Liability, Current $81,000,000 USD 6.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure -22%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $82,000,000 USD 11%
Deferred Tax Assets, Operating Loss Carryforwards $774,000,000 USD 4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Unrecognized Tax Benefits $529,000,000 USD 7.3%
Amortization of Intangible Assets $893,000,000 USD 6.4%
Depreciation, Depletion and Amortization $325,000,000 USD 6.9%
Deferred Tax Assets, Net of Valuation Allowance $3,722,000,000 USD -2.3%
Interest Expense $339,000,000 USD 17%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%